Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function.
Animals
Calcium
/ metabolism
Cell Survival
/ drug effects
Cells, Cultured
Cerebral Cortex
/ metabolism
Endoplasmic Reticulum
/ drug effects
Glutamic Acid
/ chemistry
Humans
Mitochondria
/ drug effects
Neurons
/ metabolism
Neuroprotection
/ drug effects
Neuroprotective Agents
/ chemistry
Peptides
/ chemistry
Rats
Receptors, Glutamate
/ chemistry
ROS
cationic arginine-rich peptides (CARPs)
ionotropic glutamate receptors
mitochondrial membrane potential (ΔΨm)
neuroprotection
poly-arginine-18 (R18)
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
29 Jun 2020
29 Jun 2020
Historique:
received:
22
05
2020
revised:
23
06
2020
accepted:
26
06
2020
entrez:
3
7
2020
pubmed:
3
7
2020
medline:
20
2
2021
Statut:
epublish
Résumé
Recent studies have highlighted that a novel class of neuroprotective peptide, known as cationic arginine-rich peptides (CARPs), have intrinsic neuroprotective properties and are particularly effective anti-excitotoxic agents. As such, the present study investigated the mechanisms underlying the anti-excitotoxic properties of CARPs, using poly-arginine-18 (R18; 18-mer of arginine) as a representative peptide. Cortical neuronal cultures subjected to glutamic acid excitotoxicity were used to assess the effects of R18 on ionotropic glutamate receptor (iGluR)-mediated intracellular calcium influx, and its ability to reduce neuronal injury from raised intracellular calcium levels after inhibition of endoplasmic reticulum calcium uptake by thapsigargin. The results indicate that R18 significantly reduces calcium influx by suppressing iGluR overactivation, and results in preservation of mitochondrial membrane potential (ΔΨm) and ATP production, and reduced ROS generation. R18 also protected cortical neurons against thapsigargin-induced neurotoxicity, which indicates that the peptide helps maintain neuronal survival when intracellular calcium levels are elevated. Taken together, these findings provide important insight into the mechanisms of action of R18, supporting its potential application as a neuroprotective therapeutic for acute and chronic neurological disorders.
Identifiants
pubmed: 32610439
pii: molecules25132977
doi: 10.3390/molecules25132977
pmc: PMC7412265
pii:
doi:
Substances chimiques
Neuroprotective Agents
0
Peptides
0
Receptors, Glutamate
0
polyarginine
25212-18-4
Glutamic Acid
3KX376GY7L
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University Postgraduate Award (UPA) from the University of Notre Dame, Australia.
ID : N/A
Références
Molecules. 2010 Mar 03;15(3):1168-95
pubmed: 20335972
PLoS One. 2018 Mar 7;13(3):e0193884
pubmed: 29513757
FEBS Lett. 2000 Sep 15;481(2):131-6
pubmed: 10996311
Curr Mol Med. 2004 Mar;4(2):149-77
pubmed: 15032711
Pflugers Arch. 2010 Jul;460(2):525-42
pubmed: 20229265
Cell Calcium. 2004 Sep-Oct;36(3-4):257-64
pubmed: 15261481
Front Neurosci. 2015 Dec 16;9:469
pubmed: 26733784
J Am Soc Nephrol. 2011 Jun;22(6):1041-52
pubmed: 21546574
Neuromolecular Med. 2017 Sep;19(2-3):271-285
pubmed: 28523591
Biochem Biophys Res Commun. 1995 Dec 5;217(1):144-9
pubmed: 8526902
Mol Pharmacol. 2002 May;61(5):1081-8
pubmed: 11961125
Pain. 2015 Jul;156(7):1247-1264
pubmed: 25782368
J Biol Chem. 1991 Sep 15;266(26):17067-71
pubmed: 1832668
Antioxid Redox Signal. 2008 Mar;10(3):601-19
pubmed: 17999629
J Cereb Blood Flow Metab. 2015 Jun;35(6):993-1004
pubmed: 25669902
Diabetes. 1998 Jul;47(7):1114-20
pubmed: 9648836
Acta Pharmacol Sin. 2003 Aug;24(8):746-50
pubmed: 12904272
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):E2518-27
pubmed: 23776240
J Cell Sci. 2005 Aug 1;118(Pt 15):3339-51
pubmed: 16079278
FASEB J. 2015 Nov;29(11):4589-99
pubmed: 26195590
Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1057-83
pubmed: 16710759
J Biol Chem. 2011 Oct 28;286(43):37778-92
pubmed: 21832084
Stroke. 2007 Feb;38(2 Suppl):674-6
pubmed: 17261713
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19492-7
pubmed: 19033459
Neurobiol Dis. 2006 Feb;21(2):392-403
pubmed: 16165367
Nat Biotechnol. 1998 Mar;16(3):286-91
pubmed: 9528011
Biochim Biophys Acta. 2009 Nov;1787(11):1374-82
pubmed: 19344663
Biochem Biophys Res Commun. 1997 May 8;234(1):35-8
pubmed: 9168955
Neurobiol Dis. 2019 Jan;121:17-33
pubmed: 30218759
Proc Natl Acad Sci U S A. 1989 Jul;86(14):5631-5
pubmed: 2546162
Biochem Biophys Res Commun. 2002 Jan 11;290(1):47-52
pubmed: 11779131
J Mol Neurosci. 2017 Feb;61(2):235-246
pubmed: 27866326
J Neurochem. 2011 Sep;118(6):1113-23
pubmed: 21749375
Brain Res Bull. 2017 Oct;135:62-68
pubmed: 28964774
J Biol Chem. 2017 Dec 1;292(48):19656-19673
pubmed: 28972171
Front Physiol. 2018 Jul 03;9:806
pubmed: 30018565
Stroke Res Treat. 2016;2016:2372710
pubmed: 27247825
Biochim Biophys Acta. 2015 Oct;1847(10):1075-84
pubmed: 26071084
Neuron. 2002 Mar 14;33(6):849-60
pubmed: 11906693
Br J Pharmacol. 1998 Jul;124(5):905-10
pubmed: 9692775
Nat Rev Mol Cell Biol. 2012 Sep;13(9):566-78
pubmed: 22850819
Fundam Clin Pharmacol. 1999;13(5):535-40
pubmed: 10520725
J Am Soc Nephrol. 2013 Jul;24(8):1250-61
pubmed: 23813215
Neurosci Res. 2017 Jan;114:9-15
pubmed: 27639457
Neurotherapeutics. 2020 Apr;17(2):627-634
pubmed: 31833045
J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):55-61
pubmed: 24814549
J Biol Chem. 2007 Apr 13;282(15):11590-601
pubmed: 17308309
J Neurophysiol. 2002 Sep;88(3):1279-87
pubmed: 12205149
Atherosclerosis. 2014 Sep;236(1):133-41
pubmed: 25036240
Front Neurol. 2020 Feb 25;11:108
pubmed: 32158425
Mol Brain. 2018 Feb 9;11(1):8
pubmed: 29426351
J Am Chem Soc. 2014 Dec 17;136(50):17459-67
pubmed: 25405895
J Cell Mol Med. 2011 Apr;15(4):701-17
pubmed: 21155972
Mol Pharmacol. 2005 Jul;68(1):84-9
pubmed: 15851654
Transl Neurosci. 2017 Nov 15;8:147-157
pubmed: 29177102
Neurosci Lett. 1990 Jul 3;114(2):197-202
pubmed: 1975660
Neuroscience. 2001;108(1):17-26
pubmed: 11738128
ACS Chem Neurosci. 2019 Dec 18;10(12):4800-4809
pubmed: 31710458
J Neurosci. 1996 Jul 1;16(13):4069-79
pubmed: 8753869